Zyrtec and Xyzal. Total Revenue worldwide between Y2006 and Y2013

In the last period, Y2013, the largest presented item is Zyrtec with Total Revenue of 279M. Based on the 2 presented items in the report, it seems that the entire Pharmaceuticals market declined over the 7 years between Y2006 and Y2013. At that time span the element that declined the least was Xyzal with a slowdown of 30.88%, while the element that suffered from the biggest downturn is Zyrtec with 68.47% decline over the same period. This report is based on data published by UCB